A Delhi-based CEO says he is stepping back from buying Deepinder Goyal’s proposed health device, “Temple,” after Goyal commented that the product is not made for “nationalist support” and that the company aims to compete globally. The reports describe the decision as being directly linked to Goyal’s “not made for India” framing, which the buyer interprets as excluding Indian customers.
Context across the outlets focuses on differing emphasis. One outlet highlights the Delhi CEO’s rejection tied to Goyal’s broader stance on global competition and the lack of reliance on nationalist support. Another frames the reaction as a contrast between how “global brands” approach Indian customers versus the way Goyal’s remarks were perceived. While both accounts center on the same incident and parties, they differ in the specific details highlighted and the wording used to describe the buyer’s response.